UN Decade of Healthy Ageing. [cited 2021 Oct 24]. Available from: https://www.who.int/initiatives/decade-of-healthy-ageing

Kay DW, Roth M. Environmental and hereditary factors in the schizophrenias of age (“late paraphrenia”) and their bearing on the general problem of causation in schizophrenia. J Ment Sci. 1961;107:649–86.

CAS  PubMed  Article  Google Scholar 

Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, et al. A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry. 1989;146(12):1568–74.

CAS  PubMed  Article  Google Scholar 

Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry. 2000;157(2):172–8.

CAS  PubMed  Article  Google Scholar 

Casanova MF, Stevens JR, Brown R, Royston C, Bruton C. Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol. 2002;103(4):313–20.

CAS  PubMed  Article  Google Scholar 

Nagao S, Yokota O, Ikeda C, Takeda N, Ishizu H, Kuroda S, et al. Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci. 2014;264(4):317–31.

PubMed  Article  Google Scholar 

Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry. 2003;183:213–9.

PubMed  Article  Google Scholar 

Kørner A, Lopez AG, Lauritzen L, Andersen PK, Kessing LV. Late and very-late first-contact schizophrenia and the risk of dementia--a nationwide register based study. Int J Geriatr Psychiatry. 2009;24(1):61–7.

PubMed  Article  Google Scholar 

Stafford J, Dykxhoorn J, Sommerlad A, Dalman C, Kirkbride JB, Howard R. Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study. Psychol Med. 2021:1–9. https://www.cambridge.org/core/journals/psychological-medicine/article/association-between-risk-of-dementia-and-very-lateonset-schizophrenialike-psychosis-a-swedish-populationbased-cohort-study/2F6BC9F9D4D544D1BD081B061E04F1C2.

McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743–55.

PubMed  PubMed Central  Article  Google Scholar 

Howard R, Cort E, Bradley R, Harper E, Kelly L, Bentham P, et al. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial. Lancet Psychiatry. 2018;5(7):553–63.

PubMed  PubMed Central  Article  Google Scholar 

Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, et al. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med. 2019;49(3):396–402.

PubMed  Article  Google Scholar 

Fujishiro H, Okuda M, Iwamoto K, Miyata S, Torii Y, Iritani S, et al. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [123 I]-metaiodobenzylguanidine cardiac scintigraphy. Psychiatry Clin Neurosci. 2018;72(6):423–34.

CAS  PubMed  Article  Google Scholar 

Kobayashi K, Nakano H, Akiyama N, Maeda T, Yamamori S. Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. Int J Geriatr Psychiatry. 2015;30(6):663–8.

PubMed  Article  Google Scholar 

Takahashi S, Mizukami K, Arai T, Ogawa R, Kikuchi N, Hattori S, et al. Ventilatory response to hypercapnia predicts dementia with Lewy bodies in late-onset major depressive disorder. J Alzheimers Dis. 2016;50(3):751–8.

PubMed  Article  Google Scholar 

Roberts G, Donaghy PC, Lloyd J, Durcan R, Petrides G, Colloby SJ, et al. Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies. Br J Psychiatry. 2021;218(5):276–82.

PubMed  Article  Google Scholar 

Roberts G, Durcan R, Donaghy PC, Lawley S, Ciafone J, Hamilton CA, et al. Accuracy of cardiac innervation scintigraphy for mild cognitive impairment with Lewy bodies. Neurology. 2021;96(23):e2801–11.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Suehiro T, Satake Y, Hashimoto M, Ikeda M. Case report: De Clerambault’s syndrome in dementia with Lewy bodies. Front Psych. 2021;12:665868.

Article  Google Scholar 

Mori E, Ikeda M, Kosaka K. Donepezil-DLB Study Investigators. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol. 2012;72(1):41–52.

CAS  PubMed  Article  Google Scholar 

Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):S10–6.

CAS  PubMed  Article  Google Scholar 

Tsunoda N, Hashimoto M, Ishikawa T, Fukuhara R, Yuki S, Tanaka H, et al. Clinical features of auditory hallucinations in patients with dementia with Lewy bodies: a soundtrack of visual hallucinations. J Clin Psychiatry. 2018;79(3):17m11623.

Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, et al. Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018;45(8):1405–16.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nakajima K, Matsumoto N, Kasai T, Matsuo S, Kiso K, Okuda K. Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database. Ann Nucl Med. 2016;30(3):188–99.

PubMed  PubMed Central  Article  Google Scholar 

Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36(7):1238–48.

CAS  PubMed  Google Scholar 

Rosano C, Perera S, Inzitari M, Newman AB, Longstreth WT, Studenski S. Digit Symbol Substitution test and future clinical and subclinical disorders of cognition, mobility and mood in older adults. Age Ageing. 2016;45(5):688–95.

PubMed  PubMed Central  Article  Google Scholar 

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.

PubMed  PubMed Central  Article  Google Scholar 

Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson’s disease: test-retest reproducibility. J Cereb Blood Flow Metab. 2007;27(3):597–605.

PubMed  Article  Google Scholar 

Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, et al. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med. 2009;50(10):1638–45.

CAS  PubMed  Article  Google Scholar 

Mason O, Stott J, Sweeting R. Dimensions of positive symptoms in late versus early onset psychosis. Int Psychogeriatr. 2013;25(2):320–7.

PubMed  Article  Google Scholar 

Bayram E, Coughlin DG, Banks SJ, Litvan I. Sex differences for phenotype in pathologically defined dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2021;92(7):745–50.

PubMed  Article  Google Scholar 

Utsumi K, Fukatsu R, Yamada R, Takamaru Y, Hara Y, Yasumura S. Characteristics of initial symptoms and symptoms at diagnosis in probable dementia with Lewy body disease: incidence of symptoms and gender differences. Psychogeriatrics. 2020;20(5):737–45.

PubMed  Article  Google Scholar 

Choudhury P, Graff-Radford J, Aakre JA, Wurtz L, Knopman DS, Graff-Radford NR, et al. The temporal onset of the core features in dementia with Lewy bodies. Alzheimers Dement. 2022;18(4):591–601.

PubMed  Article  Google Scholar 

Girard C, Simard M. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. Am J Geriatr Psychiatry. 2008;16(6):478–87.

PubMed  Article  Google Scholar 

Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, et al. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One. 2015;10(3):e0120540.

PubMed  PubMed Central  Article  Google Scholar 

McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6(4):305–13.

PubMed  Article  Google Scholar 

Plotkin M, Amthauer H, Klaffke S, Kühn A, Lüdemann L, Arnold G, et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (Vienna). 2005;112(5):677–92.

CAS  Article  Google Scholar 

Brooks DJ. Molecular imaging of dopamine transporters. Ageing Res Rev. 2016;30:114–21.

CAS  PubMed  Article  Google Scholar 

Fujishiro H, Iritani S, Hattori M, Sekiguchi H, Matsunaga S, Habuchi C, et al. Autopsy-confirmed hippocampal-sparing Alzheimer’s disease with delusional jealousy as initial manifestation. Psychogeriatrics. 2015;15(3):198–203.

PubMed  Article  Google Scholar 

Satake Y, Kanemoto H, Yoshiyama K, Nakahama R, Matsunaga K, Shimosegawa E, et al. Case Report: Usefulness of biomarkers for Alzheimer’s disease in two cases with very-late-onset schizophrenia-like psychosis. Front Psych. 2021;12:742659.

Article  Google Scholar